BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $26.65 million. The enterprise value is -$21.56 million.

Market Cap	26.65M
Enterprise Value	-21.56M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 58.40 million shares outstanding. The number of shares has increased by 1.67% in one year.

Current Share Class	58.40M
Shares Outstanding	58.40M
Shares Change (YoY)	+1.67%
Shares Change (QoQ)	+2.73%
Owned by Insiders (%)	6.72%
Owned by Institutions (%)	26.42%
Float	42.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.01
Forward PS	n/a
PB Ratio	1.86
P/TBV Ratio	1.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.06.

Current Ratio	3.52
Quick Ratio	3.37
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -164.30% and return on invested capital (ROIC) is -104.76%.

Return on Equity (ROE)	-164.30%
Return on Assets (ROA)	-53.71%
Return on Invested Capital (ROIC)	-104.76%
Return on Capital Employed (ROCE)	-195.19%
Revenue Per Employee	$180,328
Profits Per Employee	-$1.14M
Employee Count	61
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.91% in the last 52 weeks. The beta is 1.07, so BioAtla's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-79.91%
50-Day Moving Average	0.35
200-Day Moving Average	1.20
Relative Strength Index (RSI)	71.02
Average Volume (20 Days)	567,006

Short Selling Information

The latest short interest is 4.33 million, so 7.41% of the outstanding shares have been sold short.

Short Interest	4.33M
Short Previous Month	4.22M
Short % of Shares Out	7.41%
Short % of Float	10.24%
Short Ratio (days to cover)	5.98

Income Statement

In the last 12 months, BioAtla had revenue of $11.00 million and -$69.78 million in losses. Loss per share was -$1.44.

Revenue	11.00M
Gross Profit	-52.10M
Operating Income	-73.94M
Pretax Income	-104.56M
Net Income	-69.78M
EBITDA	-73.02M
EBIT	-73.94M
Loss Per Share	-$1.44

Full Income Statement

Balance Sheet

The company has $49.05 million in cash and $836,000 in debt, giving a net cash position of $48.21 million or $0.83 per share.

Cash & Cash Equivalents	49.05M
Total Debt	836,000
Net Cash	48.21M
Net Cash Per Share	$0.83
Equity (Book Value)	14.27M
Book Value Per Share	0.25
Working Capital	36.69M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-71.94M
Capital Expenditures	n/a
Free Cash Flow	-71.94M
FCF Per Share	-$1.23

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-672.21%
Pretax Margin	-634.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.67%
Shareholder Yield	-1.67%
Earnings Yield	-261.84%
FCF Yield	-269.94%

Analyst Forecast

The average price target for BioAtla is $1.00, which is 119.15% higher than the current price. The consensus rating is "Buy".

Price Target	$1.00
Price Target Difference	119.15%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	50.39%
EPS Growth Forecast (5Y)	-7.96%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAtla has an Altman Z-Score of -15.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.03
Piotroski F-Score	n/a